16:20 EDT Emergent BioSolutions (EBS) files $250M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Apple invests extra $100B in U.S., Trump wants Intel CEO to resign: Morning Buzz
- Emergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year
- Emergent BioSolutions narrows FY25 revenue to $765M-$835M from $750M-$850M
- Emergent BioSolutions sees Q3 revenue $180M-$210M, consensus $212.7M
- Emergent BioSolutions Reports Improved Q2 2025 Results